With the recent industry focus on a proposed ban of race day medication, particularly the anti-bleeder medication Lasix, Alicia Wincze gets some input from participants at Keeneland for the September yearling sales about how it will impact the way they buy horses.
Among those weighing in are agents Lincoln Collins and Ben Glass, and Rick Nichols, general manager of Shadwell.
“I think the impact (of no Lasix) has got to be viewed in a long term sense,” agent Lincoln Collins said during the September sale this week. “I'm 100 percent in favor of no medication at all. And I think that banning the medication in graded stakes and hopefully the Breeders' Cup is a step in the right direction. But I don't think anyone knows at this point which horses are more prone to produce bleeders and which aren't because most horses are medicated.”
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2020 Paulick Report.